The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises (2016)
Chapter: Appendix A: Public Session Agenda
Appendix A
Public Session Agenda
July 29, 2015
National Academy of Sciences Building
2101 Constitution Avenue, Lecture Room
Washington, DC
Objectives:
- The International Oversight Group will present the Statement of Task to the Commission and make any clarifications if needed.
- The expert panel will address issues of governance, finance, resilient health systems, and medical products research and development when responding to infectious disease outbreaks of international concern at the global, regional, national, and local levels. The Commission will consider the different perspectives presented as they develop the approach for this study.
|
9:00–9:05 am |
Opening Remarks |
| Peter Sands, Commission Chair | |
|
9:05–10:00 |
Background of the Initiative |
| Victor Dzau, President, National Academy of Medicine; | |
| Chair, International Oversight Group (IOG) | |
|
Reflections from IOG Members |
|
| Hugh Chang, Director, Strategy, Planning & Management for Global Development, Gates Foundation [by video-teleconference] | |
| Shigeru Omi, President, Japan Community Health Care Organization [by phone] | |
| Tan Chorh Chuan, President, National University of Singapore; IOG member [by phone] | |
|
Charge to the Commission |
|
| Judith Rodin, President of The Rockefeller Foundation; Vice-Chair of the IOG | |
|
Q and A from Commission |
|
|
10:00–10:40 |
Landscape of Other Global Initiatives |
| Ramesh Rajasingham, United Nations High Level Panel on Global Response to Health Crises | |
| Barbara Stocking [by video-teleconference] and Ilona Kickbusch, Independent Panel to Assess World Health Organization’s (WHO's) Response to Ebola | |
|
Q and A from Commission |
|
|
10:40–10:50 |
Break |
|
10:50 am–1:00 pm |
Panel: Lessons Learned on Issues of Governance, Finance, Resilient Health Systems, and Medical Product Research and Development on the Preparedness and Response to Infectious Disease Outbreaks of International Concern |
This panel will inform the commission about key challenges and lessons learned for the preparedness and response to infectious disease outbreaks of international concern. Specifically, the panelists will respond the following questions:
|
|
|
10:50 |
Introduction to the Panel |
| Patrick Kelley, Director, Board on Global Health, National Academies of Sciences, Engineering, and Medicine | |
|
11:00 |
The United Nations Response |
| David Nabarro, United Nations Special Envoy on Ebola [video presentation] | |
|
11:15 |
The World Health Organization’s Role |
| Christopher Dye, WHO Team Lead for Epidemiology and Information Management in the Ebola Response | |
|
11:30 |
Preparedness and Response at the Regional Level |
| Ron St. John, Consultant, WHO MERS Incident Manager | |
|
11:45 |
The National Government’s Capacity to Detect and Respond to a Public Health Emergency of International Concern |
| Stephen Gaojia, Head of the Ebola Emergency Operations Centre, Sierra Leone | |
|
12:00 pm |
Role of Communities—Achieving Real Community Understanding and Ownership of the Response |
| Juliet Bedford, Anthrologica |
|
12:15 |
The Role of the Private Sector—The World Economic Forum Report “Managing the Risk and Impact of Future Epidemics: Options for Public–Private Cooperation” |
| Trish Stroman, The Boston Consulting Group | |
|
12:30 |
Q and A from the Commission and IOG members |
|
1:00 |
Adjournment of Public Session |
| Peter Sands, Commission Chair |
This page intentionally left blank.
